RT Book, Section
A1 Randis, Tara M.
A1 Ratner, Adam J.
A2 Rudolph, Colin D.
A2 Rudolph, Abraham M.
A2 Lister, George E.
A2 First, Lewis R.
A2 Gershon, Anne A.
SR Print(0)
ID 7028520
T1 Chapter 292. Ureaplasma Urealyticum Infections
T2 Rudolph's Pediatrics, 22e
YR 2011
FD 2011
PB The McGraw-Hill Companies
PP New York, NY
SN 978-0-07-149723-7
LK accesspediatrics.mhmedical.com/content.aspx?aid=7028520
RD 2024/04/19
AB Shepard  first  described  Ureaplasma  urealyticum  in  1954  after  recovery  of  these  organisms  from  male  patients  with  nongonococcal  urethritis.1  Initially  referred  to  as  T-strain  (“tiny  strain”)  mycoplasma,  these  pleomorphic  organisms  measure  less  than  500  nm  in  diameter,  lack  a  cell  wall,  and  are  classified  as  members  of  the  family  Mycoplasmatacea.2Ureaplasma  differ  from  other  Mycoplasmatacea  in  that  they  produce  urease  and  therefore  are  capable  of  generating  adenosine  triphosphate  from  hydrolysis  of  urea.  This  activity  serves  as  the  primary  energy  source  for  Ureaplasma.  Ureaplasma  urealyticum  has  historically  been  subtyped  into  14  serovars.  However,  recent  molecular  characterization  of  these  serovars  has  resulted  in  a  reclassification  of  U  urealyticum  into  2  distinct  species:  U  parvum  (serovars  1,  3,  6,  and  14)  and  U  urealyticum  (serovars  2,  4,  5,  and  7–13).3